Urology

Monday

May 05

17:00 - 18:00

Mahler

Lower GI 1

Chair: Iwona Dębosz-Suwińska, Poland;

Co-Chair: Tiberiu Popescu, Romania

Overview: Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.

Session Type: Proffered Papers

Track: Clinical

Journey: GI

17:00 - 17:10

NTCP models for acute bowel toxicity and chemotherapy compliance based on LARC patients treated with 5x5 Gy and chemotherapy in the RAPIDO trial

Presenter: Max Tanaka, The Netherlands

Presentation Number: E25-479

17:10 - 17:20

Radiotherapy followed by systemic therapy and Tislelizumab in MSS rectal cancer with unresectable metastases: Results of the MIRACLE-2 study

Presenter: Fan Xia, China

Presentation Number: E25-1606

17:20 - 17:30

Factors influencing locoregional recurrence rates in rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial

Presenter: Ilaria Prata, The Netherlands

Presentation Number: E25-2500

17:30 - 17:40

Vaginal and sexual health after radiotherapy for anal cancer: A national Danish prospective cohort study

Presenter: Johanne Steffensen, Denmark

Presentation Number: E25-3391

17:40 - 17:50

Long term toxicity results of ACT4 RCT: evaluating reduced dose and standard dose chemoradiotherapy in early-stage anal cancer (ISRCTN:88455282)

Presenter: , United Kingdom

Presentation Number: E25-3895

17:50 - 18:00

Sex-disparities in anal cancer staging: is vaginal invasion as clinically relevant as invasion into other organs?

Presenter: Shefali Parikh, United Kingdom

Presentation Number: E25-4283

ESTRO 2025

Session